Contemporary Reviews in Interventional Cardiology Cardiovascular Devices and Platelet Interactions Understanding the Role of Injury, Flow, and Cellular Responses

The objectives of the 2011 Platelet Colloquium were to gain a better understanding of the role of platelets and inflammatory cells in the response to cardiovascular device– associated injury; to describe the relationship between cardiac devices, shear stress, and alterations in platelet biology and function; and to review evidence derived from in vitro, in vivo, and clinical investigations supporting therapies to modify platelet and inflammatory cell–associated responses to device-related injury. Accordingly, this review summarizes the evidence for translating basic scientific concepts underlying circulatory and device-associated vascular injury to the clinical development and use of cardiac devices, supplemented by findings from the literature. Insights for platelet receptor activation, inflammatory cell biology, endothelial dysregulation, and the effects of biomechanical stress on coagulation and hemostatic proteins were examined to better determine the pathobiology, incidence, and possible prevention of adverse events in patients receiving cardiac devices.

[1]  M. Jeong,et al.  Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial. , 2011, Journal of the American College of Cardiology.

[2]  Andrew J. Oler,et al.  Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. , 2011, Blood.

[3]  H. Dauerman.  Clinical ResearchInterventional Cardiology: Editorial CommentThe Magic of Disappearing Stents⁎ , 2011 .

[4]  Samin K. Sharma,et al.  Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. , 2011, Journal of the American College of Cardiology.

[5]  Francesco Migliavacca,et al.  Hemodynamics and In-stent Restenosis: Micro-CT Images, Histology, and Computer Simulations , 2011, Annals of Biomedical Engineering.

[6]  S. Tans,et al.  Calcium modulates force sensing by the von Willebrand factor A2 domain , 2011, Nature communications.

[7]  K. Seung,et al.  Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions. , 2011, The American journal of cardiology.

[8]  Masataka Nakano,et al.  The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. , 2011, Journal of the American College of Cardiology.

[9]  H. Hod,et al.  Statins have an early antiplatelet effect in patients with acute myocardial infarction , 2011, Platelets.

[10]  E. Edelman,et al.  Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings , 2011, Circulation.

[11]  Tae-Hoon Kim,et al.  Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound. , 2011, American heart journal.

[12]  R. Virmani,et al.  Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. , 2011, Journal of the American College of Cardiology.

[13]  M. Behnia,et al.  Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel. , 2011, Blood.

[14]  Junmei Chen,et al.  Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region. , 2010, Blood.

[15]  L. Boon,et al.  Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. , 2010, Blood.

[16]  D. Jackson,et al.  Platelets: pleiotropic roles in atherogenesis and atherothrombosis. , 2010, The international journal of biochemistry & cell biology.

[17]  Dimitrios I Fotiadis,et al.  The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans. , 2010, JACC. Cardiovascular interventions.

[18]  O. McCarty,et al.  Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. , 2010, JACC. Cardiovascular imaging.

[19]  S. Einav,et al.  Device Thrombogenicity Emulator (DTE)--design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designs. , 2010, Journal of biomechanics.

[20]  Zuo-ying Hu,et al.  Distribution and magnitude of shear stress after coronary bifurcation lesions stenting with the classical crush technique: a new predictor for in-stent restenosis. , 2010, Journal of interventional cardiology.

[21]  Andrew D. Johnson,et al.  Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study , 2010, Circulation.

[22]  Shmuel Einav,et al.  Design Optimization of a Mechanical Heart Valve for Reducing Valve Thrombogenicity—A Case Study with ATS Valve , 2010, ASAIO journal.

[23]  J. Tcheng,et al.  Intracoronary Eptifibatide Bolus Administration During Percutaneous Coronary Revascularization for Acute Coronary Syndromes With Evaluation of Platelet Glycoprotein IIb/IIIa Receptor Occupancy and Platelet Function: The Intracoronary Eptifibatide (ICE) Trial , 2010, Circulation.

[24]  K. B. Chandran,et al.  Towards Non-thrombogenic Performance of Blood Recirculating Devices , 2010, Annals of Biomedical Engineering.

[25]  A. Colombo,et al.  Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. , 2009, Journal of the American College of Cardiology.

[26]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[27]  J. Lindbäck,et al.  Stent Thrombosis in Sweden: A Report From the Swedish Coronary Angiography and Angioplasty Registry , 2009, Circulation. Cardiovascular interventions.

[28]  G. Rousseau,et al.  Existence of a microRNA pathway in anucleate platelets , 2009, Nature Structural &Molecular Biology.

[29]  H. Gurm,et al.  Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[30]  T. Springer,et al.  Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor , 2009, Proceedings of the National Academy of Sciences.

[31]  Cheng-Zhong Zhang,et al.  Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor , 2009, Science.

[32]  H. E. Speich,et al.  Variability of platelet aggregate dispersal with glycoprotein IIb–IIIa antagonists eptifibatide and abciximab , 2009, Journal of thrombosis and haemostasis : JTH.

[33]  D. Baim,et al.  Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. , 2008, JACC. Cardiovascular interventions.

[34]  R. Krams,et al.  Hemodynamic parameters regulating vascular inflammation and atherosclerosis: a brief update. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Aloke V. Finn,et al.  Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study , 2008, Circulation.

[36]  J. Sadler,et al.  Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity. , 2008, Blood.

[37]  Umberto Morbiducci,et al.  Numerical simulation of the dynamics of a bileaflet prosthetic heart valve using a fluid-structure interaction approach. , 2008, Journal of biomechanics.

[38]  A. Weyrich,et al.  Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Danny Bluestein,et al.  Biological effects of dynamic shear stress in cardiovascular pathologies and devices , 2008, Expert review of medical devices.

[40]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[41]  S. Steinhubl,et al.  Platelet function monitoring in patients with coronary artery disease. , 2007, Journal of the American College of Cardiology.

[42]  Shaun P Jackson,et al.  The growing complexity of platelet aggregation. , 2007, Blood.

[43]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[44]  D. Praticò,et al.  Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice. , 2007, Blood.

[45]  B. Nieswandt,et al.  Reduced thrombus stability in mice lacking the α2A-adrenergic receptor , 2006 .

[46]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[47]  Patrice Cacoub,et al.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. , 2006, The New England journal of medicine.

[48]  Raimund Erbel,et al.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.

[49]  S. Goto,et al.  Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling. , 2006, Journal of the American College of Cardiology.

[50]  Matthew H Samore,et al.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. , 2006, Journal of the American College of Cardiology.

[51]  Danny Bluestein,et al.  Thrombogenic Performance of a St. Jude Bileaflet Mechanical Heart Valve in a Sheep Model , 2006, ASAIO journal.

[52]  M. Kroll,et al.  Shear Stress Directly Regulates Platelet αIIbβ3 Signaling. , 2005 .

[53]  N. Prévost,et al.  Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Simon,et al.  Molecular Basis of Restenosis and Drug-Eluting Stents , 2005, Circulation.

[55]  S. Jackson,et al.  Importance of Temporal Flow Gradients and Integrin αIIbβ3 Mechanotransduction for Shear Activation of Platelets* , 2005, Journal of Biological Chemistry.

[56]  R. Lauro,et al.  Short-Term Treatment With Atorvastatin Reduces Platelet CD40 Ligand and Thrombin Generation in Hypercholesterolemic Patients , 2005, Circulation.

[57]  Mario Mazzucato,et al.  Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow. , 2004, Blood.

[58]  V. Pasceri,et al.  Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study , 2004, Circulation.

[59]  Danny Bluestein,et al.  Flow-Induced Platelet Activation in Bileaflet and Monoleaflet Mechanical Heart Valves , 2004, Annals of Biomedical Engineering.

[60]  Paul Schoenhagen,et al.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.

[61]  Jan J Piek,et al.  Impact of strut thickness on late luminal loss after coronary artery stent placement. , 2004, The American journal of cardiology.

[62]  P. Hjemdahl,et al.  Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins , 2003, Thrombosis and Haemostasis.

[63]  P. Conley,et al.  P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. , 2003, The Journal of clinical investigation.

[64]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[65]  Mario Mazzucato,et al.  Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor. , 2002, Blood.

[66]  M. Gawaz,et al.  A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation , 2002, The Journal of experimental medicine.

[67]  B. Furie,et al.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse , 2002, Nature Medicine.

[68]  R. Jordan,et al.  Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. , 2002, Journal of the American College of Cardiology.

[69]  S. Steinhubl,et al.  Point-of-care measurement of platelet function before angioplasty strongly predicts future target vessel revascularization , 2002 .

[70]  S. Jackson,et al.  Distinct Glycoprotein Ib/V/IX and Integrin αIIbβ3-dependent Calcium Signals Cooperatively Regulate Platelet Adhesion under Flow* , 2002, The Journal of Biological Chemistry.

[71]  F. Clubb,et al.  Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries , 2001, Circulation.

[72]  D. Wagner,et al.  Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. , 2001, Blood.

[73]  E. Topol,et al.  Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. , 2001, Journal of the American College of Cardiology.

[74]  B. Sobel,et al.  Platelet Reactivity Characterized Prospectively: A Determinant of Outcome 90 Days After Percutaneous Coronary Intervention , 2001, Circulation.

[75]  M. Morice,et al.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.

[76]  A. Kastrati,et al.  Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.

[77]  J. Tanguay,et al.  Recombinant Soluble P-Selectin Glycoprotein Ligand-1-Ig Reduces Restenosis Through Inhibition of Platelet-Neutrophil Adhesion After Double Angioplasty in Swine , 2001, Circulation.

[78]  U. Ikeda,et al.  Acute platelet inhibition with abciximab does not reduce in-stent restenosis. , 2000, Circulation.

[79]  M. Isobe,et al.  Roles of P-Selectin in Inflammation, Neointimal Formation, and Vascular Remodeling in Balloon-Injured Rat Carotid Arteries , 2000, Circulation.

[80]  M. Hadamitzky,et al.  Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. , 2000, Journal of the American College of Cardiology.

[81]  P. Teirstein,et al.  Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators. , 1999, Circulation.

[82]  T. Investigators.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[83]  E. Edelman,et al.  Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[84]  R. Califf,et al.  Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months , 1994, The Lancet.

[85]  A. Beaudoin,et al.  Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. , 1993, The American journal of physiology.

[86]  S. Slack,et al.  Chapter 2 Fluid dynamic and hemorheologic considerations , 1993 .

[87]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[88]  H V Anderson,et al.  Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[89]  L Schwartz,et al.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. , 1988, The New England journal of medicine.

[90]  R. Koppensteiner,et al.  High-dose atorvastatin treatment in patients with peripheral arterial disease: effects on platelet aggregation, blood rheology and plasma homocysteine. , 2011, Clinical hemorheology and microcirculation.

[91]  F. Santilli,et al.  Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. , 2011, Atherosclerosis.

[92]  Armando Tellez,et al.  Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. , 2010, JACC. Cardiovascular imaging.

[93]  K. Ley,et al.  Role of platelets in the development of atherosclerosis. , 2004, Trends in cardiovascular medicine.

[94]  S. Jackson,et al.  Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin αIIbβ3 , 2002 .

[95]  E J Topol,et al.  Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. , 1994, Lancet.

[96]  Steven M. Slack,et al.  Fluid Dynamic and Hemorheologic Considerations , 1993 .

[97]  Todd D. Giorgio,et al.  Studies on the Mechanisms of Shear-Induced Platelet Activation , 1987 .